1032281-54-1

Basic information

• Product Name: 14β-phenylpropyl-17-cyclopropylmethyl-4,5α-epoxy-6-methylenemorphinan-3,14-triol
• Synonyms: 14β-phenylpropyl-17-cyclopropylmethyl-4,5α-epoxy-6-methylenemorphinan-3,14-triol
• CAS NO: 1032281-54-1
• Molecular Weight: 457.613
• Mol File: 1032281-54-1.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: 14β-phenylpropyl-17-cyclopropylmethyl-4,5α-epoxy-6-methylenemorphinan-3,14-triol(CAS DataBase Reference)
• NIST Chemistry Reference: 14β-phenylpropyl-17-cyclopropylmethyl-4,5α-epoxy-6-methylenemorphinan-3,14-triol(1032281-54-1)
• EPA Substance Registry System: 14β-phenylpropyl-17-cyclopropylmethyl-4,5α-epoxy-6-methylenemorphinan-3,14-triol(1032281-54-1)

Safety Data

• Hazardous Substances Data: 1032281-54-1(Hazardous Substances Data)

Upstream product

• 55096-26-9 nalmefene 
• 144265-45-2 C₂₂H₂₇NO₃ 
• 646033-40-1 17-cyclopropylmethyl-4,5α-epoxy-3-methoxy-14β-(3-phenylpropyloxy)morphinan-6-one 
• 1032281-51-8 17-cyclopropylmethyl-4,5α-epoxy-3-benzyloxy-14-(3'-phenylpropoxy)-6-methylene morphinan 

Relevant articles and documents

NOVEL OPIOID COMPOUNDS AND THEIR USES

The present invention relates to opioid compounds, especially to C14 esters and ethers of naltrexone and analogues thereof. The present invention also relates to compositions, methods and medical uses that employ such compounds. More specifically, the pre

N-OXIDES OF 4,5-EPOXY-MORPHINANIUM ANALOGS

Novel N-oxides of 4,5-epoxy-morphinanium analogs are disclosed. Pharmaceutical compositions containing the N-oxides of 4,5-epoxy-morphinanium analogs and methods of their pharmaceutical uses are also disclosed. The compounds disclosed are useful, inter alia, as modulators of opioid receptors.